,i #aaf? ,,congress #b;d ,session ,h4 ,r4 #hafh ,,9 ,,! ,,h\se ,,( ,,repres5tatives ,septemb] #d1 #bjbj,mrs4 ,dem+s 7= h]self & ,mr4 ,quigley7 introduc$ ! foll[+ bill2 :i* 0 ref]r$ to ! ,committee on ,en]gy & ,comm]ce ,a ,,bill ,to require ! guidance ( ! ,food & ,drug ,adm9i/ration on r$uc+ ! risk ( human immunodefici5cy virus 7,,hiv71 hepatitis ,a1 & hepatitis ,b transmission by blood & blood products 7includ+ ! donor hi/ory que/ionnaire7 to be bas$ on an individual risk assessm5t ( sexual behaviors ^u :i* all donors are evaluat$ equally1 )\t reg>d to sexual ori5tation or g5d] id5tity1 & = o!r purposes4 #a4 ,%ort title ,?is ,act may be cit$ z ! ,sci5ce 9 ,blood ,donation ,act ( #bjbj4 #b4 ,requir+ guidance on r$uc+ risk ( ,,hiv1 hepatitis ,a1 & hepatitis ,b transmission by blood products to be bas$ on an individual risk assessm5t 7a7 ,9 g5]al ,! ,secret>y ( ,heal? & ,human ,s]vices act+ ?r\gh ! ,commission] ( ,food & ,drugs 79 ?is section ref]r$ to z ! ,secret>y7 %all-- 7#a7 n lat] ?an #de days aft] ! date ( enactm5t ( ?is ,act1 revise & publi% ! guidance ( ! ,food & ,drug ,adm9i/ration on r$uc+ ! risk ( human immunodefici5cy virus1 hepatitis ,a1 & hepatitis ,b transmission by blood & blood products s z to elim9ate-- 7,a7 ! recomm5dation to def] = #c mon?s f ! mo/ rec5t sexual contact1 a man :o has _h sex ) ano!r man dur+ ! pa/ #c mon?s2 & 7,b7 ! recomm5dation to def] = #c mon?s f ! mo/ rec5t sexual contact1 a female :o has _h sex dur+ ! pa/ #c mon?s ) a man :o has _h sex ) ano!r man 9 ! pa/ #c mon?s2 7#b7 n lat] ?an #de days aft] ! date ( enactm5t ( ?is ,act1 initiate a process-- 7,a7 to update su* guidance-- 7i7 9 con=mity ) p>agraph 7#a72 & 7ii7 s z to ensure t su* guidance1 includ+ ! correspond+ donor def]ral recomm5dations1 are bas$ on an individual risk assessm5t ( sexual behaviors ^u :i* all donors are evaluat$ equally1 )\t reg>d to sexual ori5tation or g5d] id5tity2 & 7,b7 to update ! donor hi/ory que/ionnaire consi/5t ) ! updates "u subp>agraph 7,a72 & 7#c7 n lat] ?an #ah mon?s aft] ! date ( enactm5t ( ?is ,act-- 7,a7 complete ! process initiat$ pursuant to p>agraph 7#b72 & 7,b7 publi% ! updat$ guidance & donor hi/ory que/ionnaire4 7b7 ,special rule ,?r\gh\t ! p]iod dur+ :i* ! ,secret>y is revis+ guidance pursuant to subsection 7a77#a71 ! recomm5dations describ$ 9 subp>agraphs 7,a7 & 7,b7 ( subsections 7a77#a7 are deem$ to be elim9at$ ) respect to any individual :o-- 7#a7 is a human subject 9 rese>*2 7#b7 is be+ r\t9ely te/$ = human immunodefici5cy virus1 hepatitis ,a1 & hepatitis ,b z "p ( su* rese>*2 & 7#c7 is n f\nd1 pursuant to su* te/+1 to be positive = human immunodefici5cy virus1 hepatitis ,a1 or hepatitis ,b4 7c7 ,progress report ,! ,secret>y %all-- 7#a7 n lat] ?an ea* ( #f & #ab mon?s aft] ! date ( enactm5t ( ?is ,act1 submit a report to ! appropriate congressional committees on ! progress made pursuant to ! process "u subsection 7a77#b72 & 7#b7 n lat] ?an #ah mon?s aft] ! date ( enactm5t ( ?is ,act1 submit a f9al report to ! appropriate congressional committees on ! updat$ guidance & donor hi/ory que/ionnaire4